| Phase 3 |
| NCT06072612 |
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast… |
Breast Cancer |
Recruiting |
| NCT04205812 |
Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small… |
Metastatic Squamous Non-Small Cell Lung Cancer |
Active, Not Recruiting |
| Phase 2 |
| NCT05345002 |
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma |
Glioma |
Recruiting |
| NCT04374305 |
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related… |
Neurofibromatosis Type 2 |
Recruiting |
| NCT05594290 |
Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery |
Merkel Cell Carcinoma |
Active, Not Recruiting |
| NCT06056895 |
Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel… |
Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8 |
Active, Not Recruiting |
| NCT07425054 |
HPV ctDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Advanced-Stage… |
Anal Cancer |
Not Yet Recruiting |
| NCT05287113 |
Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line… |
Head and Neck Cancer |
Active, Not Recruiting |
| NCT04968106 |
Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas (TORNADO) |
Resectable Sarcoma |
Active, Not Recruiting |
| NCT04494009 |
PD-1 Inhibitor INCMGA00012 as Consolidation Therapy After Definitive Concurrent… |
Esophageal Cancer |
Active, Not Recruiting |
| Phase 1/2 |
| NCT06320405 |
Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients… |
Advanced Malignant Solid Neoplasm |
Recruiting |
| NCT07219576 |
Retifanlimab and Ruxolitinib In Solid Malignancies |
Non Small Cell Lung Carcinoma |
Recruiting |
| NCT04577014 |
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With… |
Soft Tissue Sarcoma |
Recruiting |
| NCT06149481 |
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine… |
Metastatic Colorectal Cancer |
Recruiting |
| NCT06873789 |
A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid… |
Solid Tumors |
Active, Not Recruiting |
| NCT07468136 |
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive… |
Anaplastic Oligodendroglioma |
Not Yet Recruiting |
| Phase 1 |
| NCT05083754 |
Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide… |
Glioblastoma Multiforme |
Recruiting |
| NCT04470024 |
Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With… |
Cancer of the Head and Neck |
Recruiting |
| NCT06179160 |
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors… |
Solid Tumors |
Recruiting |
| NCT06959537 |
A Phase Ib Study of Novel Combination (New) of Low Dose Oral CyclophoSphamide (s) to… |
Breast Cancer |
Recruiting |
| NCT04387084 |
Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic… |
Advanced Malignant Skin Neoplasm |
Active, Not Recruiting |
| NCT05743595 |
Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in… |
Unmethylated Glioblastoma |
Active, Not Recruiting |
| Early Phase 1 |
| NCT06610682 |
A Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in… |
BRAF V600E Mutation |
Recruiting |